RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

MACKENZIE FINANCIAL CORP's Holding History (CIK: 0000919859)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 22,980 Value ($000) $94 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 21,940 Value ($000) $107 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 16,184 Value ($000) $82 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 15,880 Value ($000) $84 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 15,120 Value ($000) $103 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 15,120 Value ($000) $100 Avg Close $7.17 Range $5.88 - $8.73

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	22,980	$94	$4.95	$3.81 - $7.18
Q3 2025	21,940	$107	$5.25	$4.45 - $7.15
Q2 2025	16,184	$82	$4.91	$3.79 - $6.11
Q1 2025	15,880	$84	$7.29	$5.19 - $12.36
Q4 2024	15,120	$103	$6.72	$5.60 - $9.55
Q3 2024	15,120	$100	$7.17	$5.88 - $8.73